Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Means to securely fixate pacing leads and/or sensors in vessels
Remedy for overactive bladder comprising acetic acid anilide derivative as the active ingredient
Method and system for prioritizing points of interest for display in a map using category score
System and method of automatic piloting for in-flight refuelling of aircraft, and aircraft comprising said system
Position and orientation measurement apparatus, position and orientation measurement method, and storage medium
Lithographic apparatus and device manufacturing method
Stretchable elastic laminate having increased CD elongation zones and method of production
  Randomly Featured Patents
System and method for monitoring and control of processes and machines
Connector assembly
Bipolar differential input stage with input bias current cancellation circuit
Biotinylation of proteins
Multimedia providing service
Dielectric layer for a semiconductor device and method of producing the same
Error signal calculation from a Viterbi output
Methanol conversion process
Seat track bearing for an airplane
Liquid crystal display